Free press releases distribution network?

Agency / Source: AdvaCare Pharma

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets - A new Paracetamol brand will be released by Advacare and the Ugandan company Matrix. The brand name will be
AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets

 

PRZOOM - /newswire/ - Shanghai, China, 2012/06/18 - A new Paracetamol brand will be released by Advacare and the Ugandan company Matrix. The brand name will be "Para" - AdvacarePharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AdvaCare is releasing a new Paracetamol brand with the partnership of Matrix Uganda, a leading distributor in the East Africa markets, under the brand name of “Para." Paracetamol is a widely used over-the-counter analgesic which is a pain reliever and antipyretic which is a fever reducer. It is commonly used for the relief of headaches and other minor aches and pains and is a major ingredient in numerous cold and flu remedies. In combination with opioid analgesics, paracetamol can also be used in the management of more severe pain such as post-surgical pain and providing palliative care in advanced cancer patients.

After rapidly expanding in key markets throughout 2011, AdvaCare is taking an even bigger step forward in Uganda and the East African markets. AdvaCare is now considered one of the leading providers of pharmaceuticals and medical supplies in these markets. AdvaCare has successfully distributed not only medical supplies, but also a large range of finished pharmaceuticals that includes antimalarials and veterinary products for the region.

All AdvaCare distributors and importers meet our requirements ensuring capable distribution networks, sound financial stability, and ethical business practices. Our reputation is founded not only on our quality and affordable GMP approved products and competent employees, but also on our partners and distributors ability to meet the same standards.

AdvaCare (advacarepharma.com) is a leading pharmaceutical and healthcare products company. With over 60 branded products sold worldwide and numerous generics produced under our customers' brands, AdvaCare supplies distributors, governments and hospitals with the products they need for their markets. Our wide product range, including pharmaceuticals, veterinary products, active pharmaceutical ingredients, medical supplies, and diagnostic test kits allows us to scale our resources resulting in added value for our customers and ultimately the end user. AdvaCare focuses on the best value for our customers while upholding the highest quality standards.Contact us at sales[.]advacarepharma.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AdvaCare Pharma

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Bradley Johnson - AdvacarePharma.com 
+86 2161473476 sales[.]advacarepharma.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AdvaCare Pharma securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From AdvaCare Pharma / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today